Johnson & Johnson (JNJ) Shareholder Lafleur & Godfrey Decreased Its Position as Stock Value Rose; Bank Of America Has Lifted Its Tim Participacoes S A (TSU) Position

January 14, 2018 - By Louis Casey

Lafleur & Godfrey Llc decreased its stake in Johnson & Johnson (JNJ) by 3.47% based on its latest 2017Q3 regulatory filing with the SEC. Lafleur & Godfrey Llc sold 2,796 shares as the company’s stock rose 6.85% with the market. The institutional investor held 77,848 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $10.12M, down from 80,644 at the end of the previous reported quarter. Lafleur & Godfrey Llc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $391.59 billion market cap company. The stock increased 0.67% or $0.97 during the last trading session, reaching $145.76. About 5.45 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 14, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Bank Of America Corp increased its stake in Tim Participacoes S A (TSU) by 364.43% based on its latest 2017Q3 regulatory filing with the SEC. Bank Of America Corp bought 1.39M shares as the company’s stock declined 8.89% while stock markets rallied. The institutional investor held 1.77M shares of the telecommunications equipment company at the end of 2017Q3, valued at $32.43 million, up from 382,039 at the end of the previous reported quarter. Bank Of America Corp who had been investing in Tim Participacoes S A for a number of months, seems to be bullish on the $10.01 billion market cap company. The stock increased 0.45% or $0.09 during the last trading session, reaching $19.96. About 537,309 shares traded. TIM Participações S.A. (NYSE:TSU) has risen 48.97% since January 14, 2017 and is uptrending. It has outperformed by 32.27% the S&P500.

Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It has no change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Commerce Financial Bank accumulated 1.08 million shares or 2.01% of the stock. Platinum Inv Mgmt Ltd owns 32,800 shares. Loeb Prtnrs Corporation reported 1.7% of its portfolio in Johnson & Johnson (NYSE:JNJ). Jones Fincl Cos Lllp owns 116,386 shares. Nuveen Asset Mgmt Limited reported 334,910 shares. Hamel owns 4.34% invested in Johnson & Johnson (NYSE:JNJ) for 68,545 shares. Montag A And holds 1.45% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 104,049 shares. Ipg Inv Advsrs Ltd Com stated it has 0.08% of its portfolio in Johnson & Johnson (NYSE:JNJ). Opus Invest Management Incorporated reported 49,800 shares. Tillar holds 1.67% or 16,912 shares in its portfolio. Cornercap Invest Counsel Inc reported 0.22% in Johnson & Johnson (NYSE:JNJ). London Co Of Virginia holds 0.01% or 5,534 shares in its portfolio. Alpine Woods Investors invested in 0.82% or 123,522 shares. Northstar Asset Management Limited Liability Corp reported 2.05% in Johnson & Johnson (NYSE:JNJ). Fernwood Invest Llc reported 1.61% stake.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 84 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, July 20. Jefferies maintained Johnson & Johnson (NYSE:JNJ) on Friday, July 14 with “Hold” rating. The stock of Johnson & Johnson (NYSE:JNJ) has “Overweight” rating given on Monday, May 15 by JP Morgan. The firm has “Buy” rating given on Monday, July 10 by RBC Capital Markets. The company was downgraded on Tuesday, November 29 by Barclays Capital. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Leerink Swann on Wednesday, October 18. Morgan Stanley maintained the shares of JNJ in report on Wednesday, October 18 with “Equal-Weight” rating. The firm has “Buy” rating given on Wednesday, October 19 by UBS. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Jefferies on Tuesday, September 13. The firm has “Buy” rating given on Tuesday, October 17 by BMO Capital Markets.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 EPS, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62B for 21.19 P/E if the $1.72 EPS becomes a reality. After $1.90 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.

Bank Of America Corp, which manages about $629.64 billion US Long portfolio, decreased its stake in Community Health Sys Inc New (NYSE:CYH) by 399,193 shares to 273,647 shares, valued at $2.10 million in 2017Q3, according to the filing. It also reduced its holding in Wright Med Group N V (Put) by 52,700 shares in the quarter, leaving it with 5,000 shares, and cut its stake in Abbott Labs (Call) (NYSE:ABT).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>